OpGen Inc
NASDAQ:OPGN

Watchlist Manager
OpGen Inc Logo
OpGen Inc
NASDAQ:OPGN
Watchlist
Price: 18 USD 16.13% Market Closed
Market Cap: 181.3m USD

Operating Margin

73%
Current
Improving
by 600.3%
vs 3-y average of -527.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
73%
=
Operating Income
$6.6m
/
Revenue
$9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
73%
=
Operating Income
$6.6m
/
Revenue
$9m

Peer Comparison

Country Company Market Cap Operating
Margin
US
OpGen Inc
NASDAQ:OPGN
166.2m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
382B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.8B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.2B USD
Loading...
No Stocks Found

Market Distribution

Higher than 99% of companies in the United States of America
Percentile
99th
Based on 14 112 companies
99th percentile
73%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

OpGen Inc
Glance View

Market Cap
181.3m USD
Industry
Biotechnology

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. The company is headquartered in Rockville, Maryland and currently employs 99 full-time employees. The company went IPO on 2015-05-05. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes the Curetis Unyvero System and multiplex syndromic panels, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb using next generation sequencing (NGS) technology and Artificial intelligence (AI) powered bioinformatics solutions for antibiotic response prediction, as well as the Curetis CE vitro diagnostic (IVD) marked polymerase chain reaction (PCR) based severe acute respiratory syndrome (SARS) CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.

OPGN Intrinsic Value
1.92 USD
Overvaluation 89%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
73%
=
Operating Income
$6.6m
/
Revenue
$9m
What is OpGen Inc's current Operating Margin?

The current Operating Margin for OpGen Inc is 73%, which is above its 3-year median of -527.3%.

How has Operating Margin changed over time?

Over the last 3 years, OpGen Inc’s Operating Margin has increased from -536.1% to 73%. During this period, it reached a low of -1 194.3% on Jun 30, 2023 and a high of 73% on Jul 30, 2025.

Back to Top